Grip Strength: The Overlooked Biomarker for Longevity

Doctors have measured grip strength with a simple hand dynamometer for decades, mostly as a quick check for frailty in elderly patients. Over the past ten years that humble squeeze test has become one of the most consistently replicated predictors of death from any cause in the entire epidemiological literature, and in some of the largest cohorts ever assembled it has outperformed markers doctors have relied on for far longer, including blood pressure.

That should matter to anyone who trains, not only to people worried about ageing. Grip strength is not really a story about hands. It is a readout of total muscle mass, neuromuscular quality and systemic health that happens to be extraordinarily easy to measure, and the size of the studies behind it, some running into the millions of participants, makes the signal difficult to dismiss as a statistical fluke.

A Handshake Stronger Than Blood Pressure

The most cited study in this space is the Prospective Urban Rural Epidemiology (PURE) study, which followed 139,691 adults across 17 countries spanning high, middle and low income settings for a median of four years.¹ Every 5 kg reduction in grip strength was associated with a 16% increase in all-cause mortality, a 17% increase in cardiovascular mortality, and a 7% increase in the risk of a heart attack.¹ When the same PURE cohort was later expanded to more than 155,000 participants across 21 countries and compared directly against traditional cardiovascular risk markers, grip strength predicted all-cause and cardiovascular mortality more strongly than systolic blood pressure, a number most people would assume is the more important one to track.²

This is not a single-study curiosity. A systematic review and meta-analysis pooling data from approximately two million men and women found that low muscular strength, with grip strength as the dominant measure across the pooled studies, was associated with a 34 to 56% increase in all-cause mortality risk, independent of age, sex and baseline health status.⁴

What Half a Million People Confirm

The UK Biobank cohort, one of the largest prospective health datasets in the world, offers the clearest population scale confirmation. Among 502,293 participants followed for a median of seven years, each standard deviation decrease in grip strength was associated with a 20% higher risk of all-cause mortality, a 19% higher risk of cardiovascular death, and elevated risk of respiratory disease and several cancer types.³ The association held after adjusting for age, adiposity, smoking status, socioeconomic deprivation and pre-existing disease, the kind of adjustment set that usually erodes a borderline signal considerably. Here it barely moved.³

A dose-response meta-analysis published in 2022 went further and asked what shape the actual risk curve takes, rather than simply confirming an association exists. It found mortality risk fell most steeply between the weakest grip strength values and the population average, with diminishing returns above that point, and proposed specific threshold values, around 26 kg for men and 16 kg for women, below which risk climbed sharply.⁵ Global normative data drawn from more than 2.6 million adults across dozens of countries now exist specifically so an individual's grip strength can be compared against age and sex matched peers rather than an arbitrary cutoff.⁶,⁷

Why a Weak Grip Predicts Heart Disease and Cancer

Grip strength has no direct mechanical relationship to cardiac output or tumour biology, so the association reads as strange at first. The explanation is that grip strength functions as a cheap, fast proxy for something that does have a direct relationship to those outcomes: total skeletal muscle mass and neuromuscular function.

Sarcopenia, the age-related loss of muscle mass, strength and function, is strongly correlated with reduced grip strength. A large Japanese cohort study found sarcopenic older adults carried roughly double the risk of death and disability compared with non-sarcopenic peers over an eight-year follow-up.¹⁰ Weak grip is also a marker of dynapenia and frailty more broadly, which is why a study using the China Health and Retirement Longitudinal Study found weak grip strength was independently associated with a substantially higher rate of falls, an outcome that carries its own downstream mortality risk in older adults.¹¹

Muscle itself is metabolically active tissue. It clears glucose from circulation, secretes myokines that influence systemic inflammation, and its loss tracks closely with the kind of cardiometabolic decline that raises cardiovascular and cancer risk together. A 2022 study following participants with cardiometabolic multimorbidity, the coexistence of conditions such as diabetes, heart disease and stroke, found handgrip strength independently predicted both disease progression and all-cause mortality within that already high-risk group.⁹ That suggests grip strength is not merely flagging who already has one disease, but tracking the underlying physiological resilience that determines how multiple conditions interact over time.

Power Might Matter More Than Strength Alone

A 2025 study published in Mayo Clinic Proceedings added a further layer of precision by comparing muscle power, how quickly force can be produced, against muscle strength, the maximum force alone, as predictors of mortality in middle-aged and older adults.⁸ Power was the stronger predictor of the two. This lines up with what exercise physiologists have long suspected clinically: the ability to move fast under load, not only to move a heavy load slowly, deteriorates earlier with age and disease, and may be the more sensitive signal of neuromuscular decline.⁸ It also lines up with a broader shift in how muscle function is assessed in clinical settings, where position papers increasingly recommend combining strength and physical performance measures rather than treating a single grip strength number as sufficient on its own.¹²

None of this proves grip strength causes longevity, and the honest caveat is that reverse causation is difficult to fully exclude in observational data. People in the early stages of undiagnosed disease often lose strength before other symptoms appear, which could inflate the association. But the consistency across dozens of cohorts, multiple continents, and different adjustment strategies, along with a plausible and well-studied biological mechanism in sarcopenia and neuromuscular ageing, makes reverse causation an unlikely full explanation for an effect this large and this reproducible.

The Good News: Grip Strength Is Trainable at Any Age

None of this is a fixed sentence. A 2023 network meta-analysis comparing exercise modalities specifically for sarcopenia found that resistance training, alone or combined with other modalities, produced meaningful improvements in muscle strength and physical function in older adults, and ranked among the more effective interventions studied.¹³ A separate systematic review and meta-analysis of protein intake alongside resistance exercise in healthy adults found adequate protein intake amplifies the muscle mass and strength gains from training, particularly in older populations where anabolic resistance makes the training stimulus alone less efficient than it is in younger lifters.¹⁴

The practical read is straightforward. Grip strength, and the broader muscular strength it represents, responds to the same basic training principles that build strength anywhere else in the body: progressive resistance, adequate protein, and consistency measured in months rather than weeks. It is not a fixed trait that only reveals a verdict. It is closer to a modifiable vital sign.

What This Means in Practice

The reason grip strength shows up so often in this research is not that hands are biologically special. It is that grip strength happens to be the easiest muscle output in the entire body to measure cheaply, at scale, in a hospital corridor or a research van with a handheld dynamometer. That is as much a measurement convenience story as a biology story.

ZELOS exists because the same underlying idea, that muscle output is a meaningful signal worth tracking directly rather than inferring from an external proxy, applies well beyond a single squeeze test. The muscles trained in a typical resistance session, the ones a Z1 wearable reads in real time as vastus lateralis, biceps femoris or another target muscle, are subject to the same principles this literature describes for the forearm: activation, fatigue and progressive load all shape strength and function over time. Watching one muscle work directly, rather than reading a proxy for the whole system after the fact, is the more useful version of the same idea grip strength has been quietly demonstrating in cohort studies for a decade.

Key takeaways

• Grip strength is one of the most consistently replicated predictors of all-cause mortality in the epidemiological literature, and in some large cohorts it has outperformed systolic blood pressure.

• The association is not really about the hand. Grip strength functions as a low-cost proxy for total skeletal muscle mass, neuromuscular quality and systemic metabolic health.

• Risk rises sharply below population-specific thresholds, and normative data now exist so individuals can compare their own grip strength against age and sex matched peers.

• Muscle power, how fast force is produced, may predict mortality risk even more strongly than maximum strength alone.

• Grip strength, like strength anywhere else in the body, responds to resistance training and adequate protein intake. It is a modifiable signal, not a fixed verdict.

References

1. Leong, D. P., Teo, K. K., Rangarajan, S., Lopez-Jaramillo, P., Avezum, A., Jr., Orlandini, A., Seron, P., Ahmed, S. H., Rosengren, A., Kelishadi, R., Rahman, O., Swaminathan, S., Iqbal, R., Gupta, R., Lear, S. A., Oguz, A., Yusoff, K., Zatonska, K., Chifamba, J., Igumbor, E., ... Yusuf, S. (2015). Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 386(9990), 266-273. https://doi.org/10.1016/S0140-6736(14)62000-6

2. Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., Brauer, M., Kutty, V. R., Gupta, R., Wielgosz, A., AlHabib, K. F., Dans, A., Lopez-Jaramillo, P., Avezum, A., Lanas, F., Oguz, A., Kruger, I. M., Diaz, R., Yusoff, K., Mony, P., ... Dagenais, G. (2020). Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. The Lancet, 395(10226), 795-808. https://doi.org/10.1016/S0140-6736(19)32008-2

3. Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., Pell, J. P., Gill, J. M. R., Sattar, N., & Gray, S. R. (2018). Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: Prospective cohort study of half a million UK Biobank participants. BMJ, 361, k1651. https://doi.org/10.1136/bmj.k1651

4. García-Hermoso, A., Cavero-Redondo, I., Ramírez-Vélez, R., Ruiz, J. R., Ortega, F. B., Lee, D. C., & Martínez-Vizcaíno, V. (2018). Muscular strength as a predictor of all-cause mortality in an apparently healthy population: A systematic review and meta-analysis of data from approximately 2 million men and women. Archives of Physical Medicine and Rehabilitation, 99(10), 2100-2113.e5. https://doi.org/10.1016/j.apmr.2018.01.008

5. López-Bueno, R., Andersen, L. L., Koyanagi, A., Núñez-Cortés, R., Calatayud, J., Casaña, J., & Del Pozo Cruz, B. (2022). Thresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: A systematic review with dose-response meta-analysis. Ageing Research Reviews, 82, 101778. https://doi.org/10.1016/j.arr.2022.101778

6. Dodds, R. M., Syddall, H. E., Cooper, R., Kuh, D., Cooper, C., & Sayer, A. A. (2016). Global variation in grip strength: A systematic review and meta-analysis of normative data. Age and Ageing, 45(2), 209-216. https://doi.org/10.1093/ageing/afv192

7. Tomkinson, G. R., Lang, J. J., Rubín, L., McGrath, R., Gower, B., Boyle, T., Klug, M. G., Mayhew, A. J., Blake, H. T., Ortega, F. B., Cadenas-Sanchez, C., Magnussen, C. G., Fraser, B. J., Kidokoro, T., Liu, Y., Christensen, K., & Leong, D. P. (2025). International norms for adult handgrip strength: A systematic review of data on 2.4 million adults aged 20 to 100+ years from 69 countries and regions. Journal of Sport and Health Science, 14, 101014. https://doi.org/10.1016/j.jshs.2024.101014

8. Araújo, C. G. S., Kunutsor, S. K., Eijsvogels, T. M. H., Myers, J., Laukkanen, J. A., Hamar, D., Niebauer, J., Bhattacharjee, A., de Souza e Silva, C. G., Franca, J. F., & Castro, C. L. B. (2025). Muscle power versus strength as a predictor of mortality in middle-aged and older men and women. Mayo Clinic Proceedings, 100(8), 1319-1331. https://doi.org/10.1016/j.mayocp.2025.02.015

9. Lu, Y., Li, G., Ferrari, P., Freisling, H., Qiao, Y., Wu, L., Shao, L., & Ke, C. (2022). Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity. BMC Medicine, 20, 191. https://doi.org/10.1186/s12916-022-02389-y

10. Kitamura, A., Seino, S., Abe, T., Nofuji, Y., Yokoyama, Y., Amano, H., Nishi, M., Taniguchi, Y., Narita, M., Fujiwara, Y., & Shinkai, S. (2021). Sarcopenia: Prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. Journal of Cachexia, Sarcopenia and Muscle, 12(1), 30-38. https://doi.org/10.1002/jcsm.12651

11. Liu, H., Hou, Y., Li, H., & Lin, J. (2022). Influencing factors of weak grip strength and fall: A study based on the China Health and Retirement Longitudinal Study (CHARLS). BMC Public Health, 22, 2337. https://doi.org/10.1186/s12889-022-14753-x

12. Beaudart, C., Rolland, Y., Cruz-Jentoft, A. J., Bauer, J. M., Sieber, C., Cooper, C., Al-Daghri, N., Araujo de Carvalho, I., Bautmans, I., Bernabei, R., Bruyère, O., Cesari, M., Cherubini, A., Dawson-Hughes, B., Kanis, J. A., Kaufman, J. M., Landi, F., Maggi, S., McCloskey, E., ... Fielding, R. A. (2019). Assessment of muscle function and physical performance in daily clinical practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcified Tissue International, 105(1), 1-14. https://doi.org/10.1007/s00223-019-00545-w

13. Shen, Y., Shi, Q., Nong, K., Li, S., Yue, J., Huang, J., Dong, B., Beauchamp, M., & Hao, Q. (2023). Exercise for sarcopenia in older people: A systematic review and network meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1199-1211. https://doi.org/10.1002/jcsm.13225

14. Nunes, E. A., Colenso-Semple, L., McKellar, S. R., Yau, T., Ali, M. U., Fitzpatrick-Lewis, D., Sherifali, D., Gaudichon, C., Tomé, D., Atherton, P. J., Robles, M. C., Naranjo-Modad, S., Braun, M., Landi, F., & Phillips, S. M. (2022). Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults. Journal of Cachexia, Sarcopenia and Muscle, 13(2), 795-810. https://doi.org/10.1002/jcsm.12922